Since January 2026, OpenAI, Anthropic, Microsoft, and Perplexity have each launched a dedicated consumer health product — ChatGPT Health, Claude for Healthcare, Copilot Health, and Perplexity Health, all within a single quarter. Google's Gemini-powered health coach, folded into what is now branded Google Health, arrived on a longer arc either side of that window. The pitch is identical across all of them: health data scattered across disconnected apps and portals, and AI as the interface that finally makes it legible. That race is getting all the attention. Three reports published this year by the Pan American Health Organization make the case that the more important story is elsewhere.

PAHO and the Inter-American Development Bank's Regional Report on the Status of Health Information Systems in the Americas is a maturity assessment across all 49 countries and territories in the region, built from over 240 standardized indicators collected between 2019and 2024 — the most thorough evaluation of health information readiness the region has done.

The findings: 42.8% of countries remain at the most basic maturity level, where health data barely exists in digital form at all. Only 4.1% have reached the fourth of five levels, where governance is in place and systems are integrated. None have reached the fifth and final level.

To put that concretely: when an AI health product wants to pull a patient's lab results into a conversation, those results need to exist in a structured digital format somewhere. In close to half the countries in this region, they don't.

PAHO's companion Plan of Action to Strengthen Health Information Systems, 2024-2030, quantifies the distance between where things stand and where the region needs to be. Only 4 countries currently have a regulatory framework for AI in health; the target is 30 by 2030. Fifteen countries have interoperability governance mechanisms, against a target of 35. FHIR-related interoperability standards are adopted in 12 countries, targeting 35. Just 5 have adopted ICD-11 for semantic interoperability in electronic health records, targeting 30. National digital health transformation roadmaps exist in only 3 countries, with a goal of 30. And only 7 countries have a cybersecurity incident response strategy specific to health, against a target of 15.

Every one of those figures is a prerequisite for the kind of data connectivity that consumer AI health products take for granted.

The infrastructure gap is the visible problem — it can be pointed at, measured, funded. A harder one sits underneath it: in the countries that do have digital health records, the data in those systems is not neutral. It reflects decades of who received care, who got diagnosed, and who was represented in the clinical research that trained today's models. Dermatology AI trained overwhelmingly on light skin tones misses conditions on darker skin. Pulse oximeters have been shown to systematically overestimate blood oxygen levels in darker-skinned patients. Neither is hypothetical; both are documented, and both are the predictable result of building on data that was never representative to begin with. PAHO's own guidance on AI bias in health argues that closing the infrastructure gap without addressing this in parallel risks scaling the bias alongside the AI, not correcting it.

A year ago, the live question was whether AI could responsibly handle health data. Five companies have effectively decided that it can. The harder question now is whether the health systems underneath can handle AI — and PAHO's data says most of them can't yet, not from policy resistance, but because the digital plumbing isn't there, and where it is, the data flowing through it carries the biases AI will amplify rather than correct.

The organizations doing the slower, less visible work — building interoperability standards, standing up governance frameworks, moving countries from the most basic maturity level toward the standardized middle tier, establishing bias auditing before AI reaches clinical settings —may end up mattering more than the product launches getting the coverage. Infrastructure determines who benefits. Bias determines who gets harmed. For most of the world, as of today, neither problem is solved.